Abstract
Gene transfer is an emerging therapeutic modality for a wide spectrum of diseases. Its clinical adoption is, however, limited by the lack of safe and efficient gene delivery methods. Three classes of methods are currently under evaluation. The first class consists of genetically modified viruses, which include retroviruses, adenoviruses, adeno-associated viruses, and several others. These vectors are relatively efficient. However, their clinical application is associated with significant safety concerns, such as oncogenesis and acute inflammatory response. The second class is nonviral vectors, which are composed of synthetic components. These include complexes of DNA with lipids, polymers, or their combination. Many nonviral vector formulations, which incorporate functional components to facilitate nuclease protection, cellular/tissue targeting, endosomal release, and nuclear localization, have been investigated, mostly in vitro. These efforts have resulted in incremental advances in gene transfer efficiency, requiring further improvements for clinical applications. The third class of methods is based on the use of physical energy or force. Examples are gene gun, electroporation, and magnetofection. These methods are suitable for locoregional gene delivery. In this chapter, we will provide an overview of the state-of-the-art gene transfer methods, their strengths and weaknesses, and challenges and opportunities in this critical area of research, which will, to a large extent, determine the future prospect of gene therapy in the clinic.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Gregersen, J. P. (2001) DNA vaccines. Naturwissenschaften 88, 504–513.
Freeman, S. M., Abboud, C. N., Whartenby, K. A., et al. (1993) The “bystander effect”: tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53, 5274–5283.
Blaese, R. M., Culver, K. W., Miller, A. D., et al. (1995) T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270, 475–480.
Schroder, A. R., Shinn, P., Chen, H., Berry, C., Ecker, J. R., and Bushman, F. (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110, 521–529.
Wu, X., Li, Y., Crise, B., and Burgess, S. M. (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300, 1749–1751.
Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., et al. (2000) Gene therapy of human severe combined immune deficiency (SCID)-X1 disease. Science 288, 669–672.
Romano, G. (2005) Current development of lentiviral-mediated gene transfer. Drug News Perspect. 18, 128–134.
Kumar, M., Keller, B., Makalou, N., and Sutton, R. E. (2001) Systematic determination of the packaging limit of lentiviral vectors. Hum. Gene Ther. 12, 1893–1905.
De Palma, M., Venneri, M. A., and Naldini, L. (2003) In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors. Hum. Gene Ther. 14, 1193–1206.
Totsugawa, T., Kobayashi, N., Maruyama, M., et al. (2003) Lentiviral vector: a useful tool for transduction of human liver endothelial cells. ASAIO J. 49, 635–640.
Consiglio, A., Gritti, A., Dolcetta, D. (2004) Robust in vivo gene transfer into adult mammalian neural stem cells by lentiviral vectors. Proc. Natl Acad. Sci. U. S. A. 101, 14,835–14,840.
Ma, Y., Ramezani, A., Lewis, R., Hawley, R. G., and Thomson, J. A. (2003) High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells 21, 111–117.
Woods, N. B., Mikkola, H., Nilsson, E., Olsson, K., Trono, D., and Karlsson, S. (2001) Lentiviral-mediated gene transfer into haematopoietic stem cells. J. Intern. Med. 249, 339–343.
Condiotti, R., Curran, M. A., Nolan, G. P., et al. (2004) Prolonged liver-specific transgene expression by a non-primate lentiviral vector. Biochem. Biophys. Res. Commun. 320, 998–1006.
Stein, C. S., Kang, Y., Sauter, S. L., et al. (2001) In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors. Mol. Ther. 3, 850–856.
Cefai, D., Simeoni, E., Ludunge, K. M., et al. (2005) Multiply attenuated, selfinactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo. J. Mol. Cell Cardiol. 38, 333–344.
Wong, L. F., Ralph, G. S., Walmsley, L. E., et al. (2005) Lentiviral-mediated delivery of Bcl-2 or GDNF protects against excitotoxicity in the rat hippocampus. Mol. Ther. 11, 89–95.
Vigna, E. and Naldini, L. (2000) Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J. Gene Med. 2, 308–316.
Zufferey, R., Dull, T., Mandel, R. J., et al. (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72, 9873–9880.
Harui, A., Suzuki, S., Kochanek, S., and Mitani, K. (1999) Frequency and stability of chromosomal integration of adenovirus vectors. J. Virol. 73, 6141–6146.
Kochanek, S., Schiedner, G., and Volpers, C. (2001) High-capacity ‘gutless’ adenoviral vectors. Curr. Opin. Mol. Ther. 3, 454–463.
Kim, I. H., Jozkowicz, A., Piedra, P. A., Oka, K., and Chan, L. (2001) Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector. Proc. Natl Acad. Sci. U. S. A. 98, 13,282–13,287.
Dudley, R. W., Lu, Y., Gilbert, R., et al. (2004) Sustained improvement of muscle function one year after full-length dystrophin gene transfer into mdx mice by a gutted helper-dependent adenoviral vector. Hum. Gene Ther. 15, 145–156.
Kotin, R. M., Siniscalco, M., Samulski, R. J., et al. (1990) Site-specific integration by adeno-associated virus. Proc. Natl Acad. Sci. U. S. A. 87, 2211–2215.
Kearns, W. G., Afione, S. A., Fulmer, S. B., et al. (1996) Recombinant adenoassociated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther. 3, 748–755.
Nakai, H., Storm, T. A., and Kay, M. A. (2000) Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors. Nat. Biotechnol. 18, 527–532.
Flotte, T. R. (2005) Recent developments in recombinant AAV-mediated gene therapy for lung diseases. Curr. Gene Ther. 5, 361–366.
Wang, L. and Herzog, R. W. (2005) AAV-mediated gene transfer for treatment of hemophilia. Curr. Gene Ther. 5, 349–360.
Athanasopoulos, T., Graham, I. R., Foster, H., and Dickson, G. (2004) Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD). Gene Ther. 11(Suppl 1), S109–S121.
Ruitenberg, M. J., Eggers, R., Boer, G. J., and Verhaagen, J. (2002) Adenoassociated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system. Methods 28, 182–194.
Martin, K. R., Klein, R. L., and Quigley, H. A. (2002) Gene delivery to the eye using adeno-associated viral vectors. Methods 28, 267–275.
Cottard, V., Mulleman, D., Bouille, R, Mezzina, M., Boissier, M. C., and Bessis, N. (2000) Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis. Gene Ther. 7, 1930–1939.
Latchman, D. S. (2001) Gene delivery and gene therapy with herpes simplex virus-based vectors. Gene 264, 1–9.
Moriuchi, S., Wolfe, D., Tamura, M., et al. (2002) Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal interference in a malignant glioma model. Gene Ther. 9, 584–591.
Mata, M., Glorioso, J., and Fink, D. J. (2003) Development of HSV-mediated gene transfer for the treatment of chronic pain. Exp. Neurol. 184(Suppl 1), S25–S29.
Fink, D. J., Glorioso, J., and Mata, M. (2003) Therapeutic gene transfer with herpesbased vectors: studies in Parkinson’s disease and motor nerve regeneration. Exp. Neurol. 184(Suppl 1), S19–S24.
Natsume, A., Mata, M., Wolfe, D., et al. (2002) Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effect. J. Neurotrauma 19, 61–68.
Smith, G. L. and Moss, B. (1983) Infectious poxvirus vectors have capacity for at least 25,000 base pairs of foreign DNA. Gene 25, 21–28.
Chen, B., Timiryasova, T. M., Andres, M. L., et al. (2000) Evaluation of combined vaccinia virus-mediated antitumor gene therapy with p53, IL-2, and IL-12 in a glioma model. Cancer Gene Ther. 7, 1437–1447.
Kaufman, H. L., Flanagan, K., Lee, C. S., Perretta, D. J., and Horig, H. (2002) Insertion of interleukin-2 (IL-2) and interleukin-12 (IL-12) genes into vaccinia virus results in effective anti-tumor responses without toxicity. Vaccine 20, 1862–1869.
Timiryasova, T. M., Gridley, D. S., Chen, B., et al. (2003) Radiation enhances the anti-tumor effects of vaccinia-p53 gene therapy in glioma. Technol Cancer Res. Treat. 2, 223–235.
Gulley, J., Chen, A. P., Dahut, W., et al. (2002) Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgenindependent prostate cancer. Prostate 53, 109–117.
Wagner, E., Cotten, M., Foisner, R., and Birnstiel, M. L. (1991) Transferrinpolycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells. Proc. Natl Acad. Sci. U. S. A. 88, 4255–4259.
Abdelhady, H. G., Allen, S., Davies, M. C., Roberts, C. J., Tendler, S. J., and Williams, P. M. (2003) Direct real-time molecular scale visualisation of the degradation of condensed DNA complexes exposed to DNase I. Nucleic Acids Res. 31, 4001–4005.
Sternberg, B., Sorgi, F. L., and Huang, L. (1994) New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy. FEBS Lett. 356, 361–366.
Schaffer, D. V., Fidelman, N. A., Dan, N., and Lauffenburger, D. A. (2000) Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol. Bioeng. 67, 598–606.
Dash, P. R., Read, M. L., Barrett, L. B., Wolfert, M. A., and Seymour, L. W. ( 1999) Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther. 6, 643–650.
Hong, K., Zheng, W., Baker, A., and Papahadjopoulos, D. (1997) Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett. 400, 233–237.
Toncheva, V., Wolfert, M. A., Dash, P. R., et al. (1998) Novel vectors for gene delivery formed by self-assembly of DNA with poly(l-lysine) grafted with hydrophilic polymers. Biochim. Biophys. Acta 1380, 354–368.
Kircheis, R., Wightman, L., Schreiber, A., et al. (2001) Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther. 8, 28–40.
Mishra, S., Webster, P., and Davis, M. E. (2004) PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. Eur. J. Cell Biol. 83, 97–111.
Frederiksen, K. S., Abrahamsen, N., Cristiano, R. J., Damstrup, L., and Poulsen, H. S. (2000) Gene delivery by an epidermal growth factor/DNA polyplex to small cell lung cancer cell lines expressing low levels of epidermal growth factor receptor. Cancer Gene Ther. 7, 262–268.
Chiu, S. J., Ueno, N. T., and Lee, R. J. (2004) Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine. J. Control. Release 97, 357–369.
Lee, R. J. and Huang, L. (1996) Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J. Biol. Chem. 271, 8481–8487.
Labat-Moleur, F., Steffan, A. M., Brisson, C., et al. (1996) An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Ther. 3, 1010–1017.
Tseng, W. C., Haselton, F. R., and Giorgio, T. D. (1997) Transfection by cationic liposomes using simultaneous single cell measurements of plasmid delivery and transgene expression. J. Biol. Chem. 272, 25,641–25,647.
Hasegawa, S., Hirashima, N., and Nakanishi, M. (2001) Microtubule involvement in the intracellular dynamics for gene transfection mediated by cationic liposomes. Gene Ther. 8, 1669–1673.
Xu, Y. and Szoka, F. C. Jr. (1996) Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 35, 5616–5623.
Hui, S.W., Langner, M., Zhao, Y. L., Ross, P., Hurley, E., and Chan, K. (1996) The role of helper lipids in cationic liposome-mediated gene transfer. Biophys. J. 71, 590–599.
Wagner, E., Plank, C., Zatloukal, K., Cotten, M., and Birnstiel, M. L. (1992) Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc. Natl Acad. Sci. U. S. A. 89, 7934–7938.
Lee, H., Jeong, J. H., and Park, T. G. (2001) A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide. J. Control. Release 76, 183–192.
Boussif, O., Lezoualc’h, F., Zanta, M. A., et al. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl Acad. Sci. U. S. A. 92, 7297–7301.
Pack, D. W., Hoffman, A. S., Pun, S., and Stayton, P. S. (2005) Design and development of polymers for gene delivery. Nat. Rev. Drug Discov. 4, 581–593.
Legendre, J. Y. and Szoka, F. C. Jr. (1992) Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes. Pharm. Res. 9, 1235–1242.
Lukacs, G. L., Haggie, P., Seksek, O., Lechardeur, D., Freedman, N., and Verkman, A. S. (2000) Size-dependent DNA mobility in cytoplasm and nucleus. J. Biol. Chem. 275, 1625–1629.
Lechardeur, D., Sohn, K. J., Haardt, M., et al. (1999) Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther. 6, 482–497.
Ryan, K. J. and Wente, S. R. (2000) The nuclear pore complex: a protein machine bridging the nucleus and cytoplasm. Curr. Opin. Cell Biol. 12, 361–371.
Brunner, S., Sauer, T., Carotta, S., Cotten, M., Saltik, M., and Wagner, E. (2000) Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther. 7, 401–407.
Zanta, M. A., Belguise-Valladier, P., and Behr, J. P. (1999) Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl Acad. Sci. U. S. A. 96, 91–96.
Branden, L. J., Mohamed, A. J., and Smith, C. I. (1999) A peptide nucleic acidnuclear localization signal fusion that mediates nuclear transport of DNA. Nat. Biotechnol. 17, 784–787.
Chan, C. K. and Jans, D. A. (1999) Enhancement of polylysine-mediated transferrinfection by nuclear localization sequences: polylysine does not function as a nuclear localization sequence. Hum. Gene Ther. 10, 1695–1702.
Chan, C. K., Senden, T., and Jans, D. A. (2000) Supramolecular structure and nuclear targeting efficiency determine the enhancement of transfection by modified polylysines. Gene Ther. 7, 1690–1697.
Bremner, K. H., Seymour, L. W., Logan, A., and Read, M. L. (2004) Factors influencing the ability of nuclear localization sequence peptides to enhance nonviral gene delivery. Bioconjug. Chem. 15, 152–161.
Tousignant, J. D., Gates, A. L., Ingram, L. A., et al. (2000) Comprehensive analy sis of the acute toxicities induced by systemic administration of cationic lipid: plasmid DNA complexes in mice. Hum. Gene Ther. 11, 2493–2513.
Freimark, B. D., Blezinger, H. P., Florack, V. J., et al. (1998) Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes. J. Immunol. 160, 4580–4586.
Qin, L., Ding, Y., Pahud, D. R., Chang, E., Imperiale, M. J., and Bromberg, J. S. (1997) Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum. Gene Ther. 8, 2019–2029.
Bird, A. P. (1986) CpG-rich islands and the function of DNA methylation. Nature 321, 209–213.
Krieg, A. M. (1999) Direct immunologic activities of CpG DNA and implications for gene therapy. J. Gene Med. 1, 56–63.
Felgner, P. L., Gadek, T. R., Holm, M., et al. (1987) Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl Acad. Sci. U. S. A. 84, 7413–7417.
Gao, X. and Huang, L. (1991) A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179, 280–285.
Lee, E. R., Marshall, J., Siegel, C. S., et al. (1996) Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum. Gene Ther. 7, 1701–1717.
Caplen, N. J., Alton, E. W., Middleton, P. G., et al. (1995) Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat. Med. 1, 39–46.
McLachlan, G., Ho, L. P., Davidson-Smith, H., et al. (1996) Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR-DOTAP. Gene Ther. 3, 1113–1123.
Gill, D. R., Southern, K. W., Mofford, K. A., et al. (1997) A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 4, 199–209.
Laemmli, U. K. (1975) Characterization of DNA condensates induced by poly (ethylene oxide) and polylysine. Proc. Natl Acad. Sci. U. S. A. 72, 4288–4292.
Akinc, A. and Langer, R. (2002) Measuring the pH environment of DNA delivered using nonviral vectors: implications for lysosomal trafficking. Biotechnol. Bioeng. 78, 503–508.
Forrest, M. L. and Pack, D. W. (2002) On the kinetics of polyplex endocytic trafficking: implications for gene delivery vector design. Mol. Ther. 6, 57–66.
Mislick, K. A., Baldeschwieler, J. D., Kayyem, J. F., and Meade, T. J. (1995) Transfection of folate-polylysine DNA complexes: evidence for lysosomal delivery. Bioconjug. Chem. 6, 512–515.
Suh, W., Chung, J. K., Park, S. H., and Kim, S. W. (2001) Anti-JL1 antibodyconjugated poly (l-lysine) for targeted gene delivery to leukemia T cells. J. Control. Release 72, 171–178.
Leamon, C. P., Weigl, D., and Hendren, R. W. (1999) Folate copolymer-mediated transfection of cultured cells. Bioconjug. Chem. 10, 947–957.
Harbottle, R. P., Cooper, R. G., Hart, S. L., et al. (1998) An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene delivery. Hum. Gene Ther. 9, 1037–1047.
Zatloukal, K., Wagner, E., Cotten, M., et al. (1992) Transferrinfection: a highly efficient way to express gene constructs in eukaryotic cells. Ann. N. Y. Acad. Sci. 660, 136–153.
Choi, Y. H., Liu, F., Kim, J. S., Choi, Y. K., Park, J. S., and Kim, S. W. (1998) Polyethylene glycol-grafted poly-l-lysine as polymeric gene carrier. J. Control. Release 54, 39–48.
Lim, Y. B., Han, S. O., Kong, H. U., et al. (2000) Biodegradable polyester, poly[alpha-(4-aminobutyl)-l-glycolic acid], as a non-toxic gene carrier. Pharm. Res. 17, 811–816.
Benns, J. M., Maheshwari, A., Furgeson, D. Y., Mahato, R. I., and Kim, S. W. (2001) Folate-PEG-folate-graft-polyethylenimine-based gene delivery. J. Drug Target 9, 123–139.
Kircheis, R., Blessing, T., Brunner, S., Wightman, L., and Wagner, E. (2001) Tumor targeting with surface-shielded ligand-polycation DNA complexes. J. Control. Release 72, 165–170.
Haensler, J. and Szoka, F. C. Jr. (1993) Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug. Chem. 4, 372–379.
Murthy, N., Robichaud, J. R., Tirrell, D. A., Stayton, P. S., and Hoffman, A. S. (1999) The design and synthesis of polymers for eukaryotic membrane disruption. J. Control Release 61, 137–143.
Kyriakides, T. R., Cheung, C. Y., Murthy, N., Bornstein, P., Stayton, P. S., and Hoffman, A. S. (2002) pH-sensitive polymers that enhance intracellular drug delivery in vivo. J. Control. Release 78, 295–303.
Murthy, N., Campbell, J., Fausto, N., Hoffman, A. S., and Stayton, P. S. (2003) Design and synthesis of pH-responsive polymeric carriers that target uptake and enhance the intracellular delivery of oligonucleotides. J. Control. Release 89, 365–374.
Lim, Y., Choi, Y H., and Park, J. (1999) A Self-Destroying Polycationic Polymer: Biodegradable Poly(4-hydroxy-l-proline ester). J. Am. Chem. Soc. 121, 5633–5639.
Lim, Y., Kim, S. M., Lee, Y., et al. (2001) Cationic hyperbranched poly(amino ester): a novel class of DNA condensing molecule with cationic surface, biodegradable three-dimensional structure, and tertiary amine groups in the interior. J. Am. Chem. Soc. 123, 2460–2461.
Forrest, M. L., Koerber, J. T., and Pack, D. W. (2003) A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjug. Chem. 14, 934–940.
Gonzalez, H., Hwang, S. J., and Davis, M. E. (1999) New class of polymers for the delivery of macromolecular therapeutics. Bioconjug. Chem. 10, 1068–1074.
Borchard, G. (2001) Chitosans for gene delivery. Adv. Drug Deliv. Rev. 52, 145–150.
Gao, X. and Huang, L. (1996) Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry 35, 1027–1036.
Graessmann, M. and Graessmann, A. (1983) Microinjection of tissue culture cells. Methods Enzymol. 101, 482–492.
Masuda, T., Akita, H., and Harashima, H. (2005) Evaluation of nuclear transfer and trans-cription of plasmid DNA condensed with protamine by microinjection: the use of a nuclear transfer score. FEBS Lett. 579, 2143–2148.
Hammer, R. E., Pursel, V. G., Rexroad, C. E. Jr., et al. (1985) Production of transgenic rabbits, sheep and pigs by microinjection. Nature 315, 680–683.
Matsuoka, H., Komazaki, T., Mukai, Y., et al. (2005) High throughput easy microinjection with a single-cell manipulation supporting robot. J. Biotechnol. 116, 185–194.
Yang, N. S., Burkholder, J., Roberts, B., Martinell, B., and McCabe, D. (1990) In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Natl Acad. Sci. U. S. A. 87, 9568–9572.
O’Brien, J. and Lummis, S. C. (2004) Biolistic and diolistic transfection: using the gene gun to deliver DNA and lipophilic dyes into mammalian cells. Methods 33, 121–125.
Murphy, R. C. and Messer, A. (2001) Gene transfer methods for CNS organotypic cultures: a comparison of three nonviral methods. Mol. Ther. 3, 113–121.
Kuriyama, S., Mitoro, A., Tsujinoue, H., et al. (2000) Particle-mediated gene transfer into murine livers using a newly developed gene gun. Gene Ther. 7, 1132–1136.
Lauritzen, H. P., Reynet, C., Schjerling, P., et al. (2002) Gene gun bombardmentmediated expression and translocation of EGFP-tagged GLUT4 in skeletal muscle fibres in vivo. Pflugers Arch. 444, 710–721.
Sato, H., Hattori, S., Kawamoto, S., et al. (2000) In vivo gene gun-mediated DNA delivery into rodent brain tissue. Biochem. Biophys. Res. Commun. 270, 163–170.
Matsuno, Y., Iwata, H., Umeda, Y., et al. (2003) Nonviral gene gun mediated transfer into the beating heart. ASAIO J. 49, 641–644.
Chuang, Y. C., Yang, L. C., Chiang, P. H., et al. (2005) Gene gun particle encoding preproenkephalin cDNA produces analgesia against capsaicin-induced bladder pain in rats. Urology 65, 804–810.
Lin, M. T., Pulkkinen, L., Uitto, J., and Yoon, K. (2000) The gene gun: current applications in cutaneous gene therapy. Int. J. Dermatol. 39, 161–170.
Dean, H. J., Haynes, J., and Schmaljohn, C. (2005) The role of particle-mediated DNA vaccines in biodefense preparedness. Adv. Drug Deliv. Rev. 57, 1315–1342.
Trimble, C., Lin, C. T., Hung, C. F., et al. (2000) Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe. Vaccine 21, 4036–4042.
Davidson, J. M., Krieg, T., and Eming, S. A. (2000) Particle-mediated gene therapy of wounds. Wound Repair Regen. 8, 452–459.
Furth, P. A., Shamay, A., and Hennighausen, L. (1995) Gene transfer into mammalian cells by jet injection. Hybridoma 14, 149–152.
Haensler, J., Verdelet, C., Sanchez, V., et al. (1999) Intradermal DNA immunization by using jet-injectors in mice and monkeys. Vaccine 17, 628–638.
Lundholm, P., Asakura, Y., Hinkula, J., Lucht, E., and Wahren, B. (1999) Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA. Vaccine 17, 2036–2042.
Horiki, M., Yamato, E., Ikegami, H., Ogihara, T., and Miyazaki, J. Needleless in vivo gene transfer into muscles by jet injection in combination with electroporation. J. Gene Med. 6, 1134–1138.
Walther, W., Stein, U., Fichtner, L, Malcherek, L., Lemm, M., and Schlag, P. M. (2001) Nonviral in vivo gene delivery into tumors using a novel low volume jetinjection technology. Gene Ther. 8, 173–180.
Walther, W., Stein, U., Fichtner, I., et al. (2002) Intratumoral low-volume jetinjection for efficient nonviral gene transfer. Mol. Biotechnol. 21, 105–115.
Walther, W., Stein, U., Siegel, R., Fichtner, I., and Schlag, P. M. (2005) Use of the nuclease inhibitor aurintricarboxylic acid (ATA) for improved non-viral intratumoral in vivo gene transfer by jet-injection. J. Gene Med. 7, 477–485.
Spassova, M., Tsoneva, I., Petrov, A. G., Petkova, J. I., and Neumann, E. (1994) Dip patch clamp currents suggest electrodiffusive transport of the polyelectrolyte DNA through lipid bilayers. Biophys. Chem. 52, 267–274.
Chang, D. C. (1992) Structure and dynamics of electric field-induced membrane pores as revealed by rapid-freezing electron microscopy. In: Guide to Electroporation and Electrofusion (Chang, D. C., Chassy, B. M., Saunders, J. A., and Sowers, A. E., eds), Academic Press, San Diego, pp. 9–27.
Mir, L. M., Bureau, M. F., Gehl, J., et al. (1999) High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl Acad. Sci. U. S. A. 96, 4262–4267.
Leclere, P. G., Panjwani, A., Docherty, R., Berry, M., Pizzey, J., and Tonge, D. A. (2005) Effective gene delivery to adult neurons by a modified form of electroporation. J. Neurosci. Methods 142, 137–143.
Hamm, A., Krott, N., Breibach, I., Blindt, R., and Bosserhoff, A. K. (2002) Efficient transfection method for primary cells. Tissue Eng. 8, 235–245.
Lakshmipathy, U., Pelacho, B., Sudo, K., et al. (2004) Efficient transfection of embryonic and adult stem cells. Stem Cells 22, 531–543.
Jeong, J. G., Kim, J. M., Ho, S. H., Hahn, W., Yu, S. S., and Kim, S. (2004) Electrotransfer of human IL-1Ra into skeletal muscles reduces the incidence of murine collagen-induced arthritis. J. Gene Med. 6, 1125–1133.
Bettan, M., Emmanuel, F., Darteil, R., et al. (2000) High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle. Mol. Ther. 2, 204–210.
Long, Y. C., Jaichandran, S., Ho, L. P., Tien, S. L., Tan, S. Y., and Kon, O. L. (2005) FVIII gene delivery by muscle electroporation corrects murine hemophilia A. J. Gene Med. 7, 494–505.
Tjelle, T. E., Corthay, A., Lunde, E., et al. (2004) Monoclonal antibodies produced by muscle after plasmid injection and electroporation. Mol. Ther. 9, 328–336.
Rizzuto, G., Cappelletti, M., Maione, D., et al. (1999) Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc. Natl Acad. Sci. U. S. A. 96, 6417–6422.
Muramatsu, T., Arakawa, S., Fukazawa, K., et al. (2001) In vivo gene electroporation in skeletal muscle with special reference to the duration of gene expression. Int. J. Mol. Med. 7, 37–42.
Murakami, T., Nishi, T., Kimura, E., et al. (2003) Full-length dystrophin cDNA transfer into skeletal muscle of adult mdx mice by electroporation. Muscle Nerve 27, 237–241.
Ferrer, A., Foster, H., Wells, K. E., Dickson, G., and Wells, D. J. (2004) Longterm expression of full-length human dystrophin in transgenic mdx mice expressing internally deleted human dystrophins. Gene Ther. 11, 884–893.
Medi, B. M., Hoselton, S., Marepalli, R. B., and Singh, J. (2005) Skin targeted DNA vaccine delivery using electroporation in rabbits. I: efficacy. Int. J. Pharm. 294, 53–63.
Kobayashi, S., Dono, K., Takahara, S., et al. (2003) Electroporation-mediated ex vivo gene transfer into graft not requiring injection pressure in orthotopic liver transplantation. J. Gene Med. 5, 510–517.
Harrison, R. L., Byrne, B. J., and Tung, L. (1998) Electroporation-mediated gene transfer in cardiac tissue. FEBS Lett. 435, 1–5.
Dean, D. A., Machado-Aranda, D., Blair-Parks, K., Yeldandi, A. V., and Young, J. L. (2003) Electroporation as a method for high-level nonviral gene transfer to the lung. Gene Ther. 10, 1608–1615.
Dezawa, M., Takano, M., Negishi, H., Mo, X., Oshitari, T., and Sawada, H. (2002) Gene transfer into retinal ganglion cells by in vivo electroporation: a new approach. Micron 33, 1–6.
Wei, F., Xia, X. M., Tang, J., et al. (2003) Calmodulin regulates synaptic plasticity in the anterior cingulate cortex and behavioral responses: a microelectroporation study in adult rodents. J. Neurosci. 23, 8402–8409.
Bettan, M., Ivanov, M. A., Mir, L. M., Boissiere, F., Delaere, P., and Scherman, D. (2000) Efficient DNA electrotransfer into tumors. Bioelectrochemistry 52, 83–90.
Babiuk, S., Baca-Estrada, M. E., Foldvari, M., et al. (2004) Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines. J. Biotechnol. 110, 1–10.
Bao, S., Thrall, B. D., and Miller, D. L. (1997) Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med. Biol. 23, 953–959.
Marmottant, P. and Hilgenfeldt, S. (2003) Controlled vesicle deformation and lysis by single oscillating bubbles. Nature 423, 153–156.
Wu, J. (2002) Theoretical study on shear stress generated by microstreaming surrounding contrast agents attached to living cells. Ultrasound Med. Biol. 28, 125–129.
Brujan, E. A. (2004) The role of cavitation microjets in the therapeutic applications of ultrasound. Ultrasound Med. Biol. 30, 381–387.
Holt, R. G. and Roy, R. A. (2001) Measurements of bubble-enhanced heating from focused, MHz-frequency ultrasound in a tissue-mimicking material. Ultrasound Med. Biol. 27, 1399–1412.
Zhong, P., Lin, H., Xi, X., Zhu, S., and Bhoghte, E. S. (1999) Shock wave-inertial microbubble interaction: methodology, physical characterization, and bioeffect study. J. Acoust. Soc. Am. 105, 1997–2009.
Li, T., Tachibana, K., Kuroki, M., and Kuroki, M. (2003) Gene transfer with echoenhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice—initial results. Radiology 229, 423–428.
Taniyama, Y., Tachibana, K., Hiraoka, K., et al. (2002) Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther. 9, 372–380.
Taniyama, Y., Tachibana, K., Hiraoka, K., et al. (2002) Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 105, 1233–1239.
Frenkel, P. A., Chen, S., Thai, T., Shohet, R. V., and Grayburn, P. A. (2002) DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med. Biol. 28, 817–822.
Lawrie, A., Brisken, A. F., Francis, S. E., Cumberland, D. C., Crossman, D. C., and Newman, C. M. (2000) Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther. 7, 2023–2027.
Bao, S., Thrall, B. D., and Miller, D. L. (1997) Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med. Biol. 23, 953–959.
Kondo, I., Ohmori, K., Oshita, A., et al. (2004) Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a “functional” gene using ultrasonic microbubble destruction. J. Am. Coll. Cardiol. 44, 644–653.
Anwer, K., Kao, G., Proctor, B., et al. (2000) Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Ther. 7, 1833–1839.
Scherer, F., Anton, M., Schillinger, U., et al. (2002) Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 9, 102–109.
Huth, S., Lausier, J., Gersting, S. W., et al. (2004) Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J. Gene Med. 6, 923–936.
Gersting, S. W., Schillinger, U., Lausier, J., et al. (2004) Gene delivery to respiratory epithelial cells by magnetofection. J. Gene Med. 6, 913–922.
Krotz, F., Sohn, H. Y., Gloe, T., Plank, C., and Pohl, U. (2003) Magnetofection potentiates gene delivery to cultured endothelial cells. J. Vasc. Res. 40, 425–434.
Schillinger, U., Brill, T., Rudolph, C., et al. (2005) Advances in magnetofectionmagnetically guided nucleic acid delivery. J. Magnetism Magnetic Mater. 293, 501–508.
Griesenbach, U., Dean, P., Marshall, N., et al. (2004) Magnetofection and Ultrasound To Increase “Naked” DNA Delivery to the Myocardium, Mol. Ther. 9(Suppl. 1), 358.
Jiang, H., Zhang, T, and Sun, X. (2005) Vascular Endothelial Growth Factor Gene Delivery by Magnetic DNA Nanospheres Ameliorates Limb Ischemia in Rabbits. J. Surg. Res. 126, 48–54.
Xenariou, S., Griesenbach, U., Ferrari, S., et al. (2004) Magnetofection to enhance airway gene transfer. Mol. Ther. 9(Suppl. 1), 180.
Herweijer, H. and Wolff, J. A. (2003) Progress and prospects: naked DNA gene transfer and therapy. Gene Ther. 10, 453–458.
Andrianaivo, F., Lecocq, M., Wattiaux-De Coninck, S., Wattiaux, R., and Jadot, M. (2004) Hydrodynamics-based transfection of the liver: entrance into hepatocytes of DNA that causes expression takes place very early after injection. J. Gene Med. 6, 877–883.
Kobayashi, N., Nishikawa, M., Hirata, K., and Takakura, Y. (2004) Hydrodynamics-based procedure involves transient hyperpermeability in the hepatic cellular membrane: implication of a nonspecific process in efficient intracellular gene delivery. J. Gene Med. 6, 584–592.
Zhang, G., Gao, X., Song, Y. K., et al. (2004) Hydroporation as the mechanism of hydrodynamic delivery. Gene Ther. 11, 675–682.
Budker, V., Zhang, G., Danko, I., Williams, P., and Wolff, J. (1998) The efficient expression of intravascularly delivered DNA in rat muscle. Gene Ther. 5, 272–276.
Zhang, G., Budker, V., Williams, P., Subbotin, V., and Wolff, J. A. (2001) Efficient expression of naked dna delivered intraarterially to limb muscles of nonhuman primates. Hum. Gene Ther. 12, 427–438.
Liang, K. W., Nishikawa, M., Liu, F., Sun, B., Ye, Q., and Huang, L. (2004) Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA. Gene Ther. 11, 901–908.
Hagstrom, J. E., Hegge, J., Zhang, G., et al. (2004) A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. Mol. Ther. 10, 386–398.
Liu, F. and Huang, L. (2001) Improving plasmid DNA-mediated liver gene transfer by prolonging its retention in the hepatic vasculature. J. Gene Med. 3, 569–576.
Liu, F., Nishikawa, M., Clemens, P. R., and Huang, L. (2001) Transfer of fulllength Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNA. Mol. Ther. 4, 45–51.
Budker, V., Budker, T., Zhang, G., Subbotin, V., Loomis, A., and Wolff, J. A. (2000) Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptormediated process. J. Gene Med. 2, 76–88.
Miao, C. H., Thompson, A. R., Loeb, K., and Ye, X. (2001) Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo. Mol. Ther. 3, 947–957.
Maruyama, H., Higuchi, N., Nishikawa, Y., et al. (2002) High-level expression of naked DNA delivered to rat liver via tail vein injection. J. Gene Med. 4, 333–341.
Eastman, S. J., Baskin, K. M, Hodges, B. L., et al. (2002) Development of catheter-based procedures for transducing the isolated rabbit liver with plasmid DNA. Hum. Gene Ther. 13, 2065–2077.
Kurata, S., Tsukakoshi, M., Kasuya, T., and Ikawa, Y. (1986) The laser method for efficient introduction of foreign DNA into cultured cells. Exp. Cell Res. 162, 372–378.
Tao, W., Wilkinson, J., Stanbridge, E. J., and Berns, M. W. (1987) Direct gene transfer into human cultured cells facilitated by laser micropuncture of the cell membrane. Proc. Natl Acad. Sci. U. S. A. 84, 4180–4184.
Tirlapur, U. K. and Konig, K. (2002) Targeted transfection by femtosecond laser. Nature 418, 290–291.
Shirahata, Y., Ohkohchi, N., Itagak, H., and Satomi, S. (2001) New technique for gene transfection using laser irradiation. J. Investig. Med. 49, 184–190.
Terakawa, M., Ogura, M., Sato, S., et al. (2004) Gene transfer into mammalian cells by use of a nanosecond pulsed laser-induced stress wave. Opt. Lett. 29, 1227–1229.
Umebayashi, Y., Miyamoto, Y., Wakita, M., Kobayashi, A., and Nishisaka, T. (2003) Elevation of plasma membrane permeability on laser irradiation of extracellular latex particles. J. Biochem. (Tokyo) 134, 219–224.
Palumbo, G., Caruso, M., Crescenzi, E., Tecce, M. F., Roberti, G., and Colasanti, A. (1996) Targeted gene transfer in eucaryotic cells by dye-assisted laser optoporation. J. Photochem. Photobiol. B 36, 41–46.
Ogura, M., Sato, S., Nakanishi, K., et al. (2004) In vivo targeted gene transfer in skin by the use of laser-induced stress waves. Lasers Surg. Med. 34, 242–248.
Zeira, E., Manevitch, A., Khatchatouriants, A., et al. (2003) Femtosecond infrared laser-an efficient and safe in vivo gene delivery system for prolonged expression. Mol. Ther. 8, 342–350.
Song, L., Chau, L., Sakamoto, Y., Nakashima, J., Koide, M, and Tuan, R. S. (2004) Electric field-induced molecular vibration for noninvasive, high-efficiency DNA transfection.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Guan, J., Pan, X., Lee, L.J., Lee, R.J. (2008). Viral, Nonviral, and Physical Methods for Gene Delivery. In: Wu-Pong, S., Rojanasakul, Y. (eds) Biopharmaceutical Drug Design and Development. Humana Press. https://doi.org/10.1007/978-1-59745-532-9_8
Download citation
DOI: https://doi.org/10.1007/978-1-59745-532-9_8
Publisher Name: Humana Press
Print ISBN: 978-1-58829-716-7
Online ISBN: 978-1-59745-532-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)